Acute myeloid leukemia, version 2.2013.

O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland SA, Wang ES, Gregory KM, Naganuma M, National Comprehensive Cancer Network
J Natl Compr Canc Netw. 2013 11 (9): 1047-55

PMID: 24029121 · PMCID: PMC4161234 · DOI:10.6004/jnccn.2013.0127

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.

MeSH Terms (4)

Antineoplastic Combined Chemotherapy Protocols Humans Leukemia, Myeloid, Acute Leukemia, Promyelocytic, Acute

Connections (1)

This publication is referenced by other Labnodes entities: